Algert Global LLC Raises Stock Position in Xylem Inc. (NYSE:XYL)

Algert Global LLC lifted its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 798.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,481 shares of the industrial products company's stock after acquiring an additional 27,976 shares during the period. Algert Global LLC's holdings in Xylem were worth $4,251,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the company. Lazard Asset Management LLC lifted its holdings in shares of Xylem by 2.5% during the first quarter. Lazard Asset Management LLC now owns 48,894 shares of the industrial products company's stock valued at $6,318,000 after purchasing an additional 1,213 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Xylem by 0.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 325,496 shares of the industrial products company's stock valued at $42,068,000 after acquiring an additional 1,732 shares during the period. SVB Wealth LLC boosted its holdings in shares of Xylem by 14.3% during the 1st quarter. SVB Wealth LLC now owns 9,930 shares of the industrial products company's stock valued at $1,283,000 after acquiring an additional 1,241 shares during the last quarter. Silvercrest Asset Management Group LLC lifted its position in Xylem by 4.1% during the first quarter. Silvercrest Asset Management Group LLC now owns 103,602 shares of the industrial products company's stock valued at $13,390,000 after purchasing an additional 4,058 shares during the period. Finally, Virtus Investment Advisers Inc. purchased a new stake in Xylem in the first quarter worth approximately $216,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Price Performance

NYSE:XYL traded up $2.07 on Monday, reaching $128.94. 4,258,034 shares of the company's stock traded hands, compared to its average volume of 1,231,831. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12 month low of $102.42 and a 12 month high of $146.08. The stock has a 50-day simple moving average of $130.06 and a 200-day simple moving average of $134.13. The firm has a market cap of $31.33 billion, a PE ratio of 37.70, a P/E/G ratio of 2.34 and a beta of 1.05.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting the consensus estimate of $1.11. The business had revenue of $2.10 billion for the quarter, compared to analysts' expectations of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business's quarterly revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.99 EPS. Equities research analysts forecast that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, November 26th. Xylem's dividend payout ratio is presently 42.11%.

Wall Street Analysts Forecast Growth

XYL has been the topic of a number of research reports. Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Stifel Nicolaus boosted their price target on Xylem from $170.00 to $172.00 and gave the company a "buy" rating in a research note on Wednesday, July 31st. UBS Group started coverage on shares of Xylem in a research note on Tuesday, August 13th. They issued a "buy" rating and a $165.00 price objective on the stock. TD Cowen reduced their target price on shares of Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a report on Wednesday, November 6th. Finally, Royal Bank of Canada decreased their price target on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $149.64.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.